579 results on '"Cao, Davide"'
Search Results
152. Aspirin-free strategies: a framework to reassess the role of dual antiplatelet therapy after percutaneous coronary intervention
153. Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction: Bleeding Avoidance First and Foremost
154. Radial versus femoral access for coronary interventions: An updated systematic review and meta‐analysis of randomized trials
155. Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry
156. Impact of Chronic Kidney Disease on Periprocedural Anticoagulation and Short-Term Outcomes after TAVR: A BRAVO-3 Trial Subanalysis
157. Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stent
158. Sex-related differences in patients at high bleeding risk undergoing percutaneous coronary intervention: a patient-level Pooled analysis from 4 postapproval studies
159. Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey
160. Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review
161. Prevalence and prognostic impact of hsCRP elevation are age‐dependent in women but not in men undergoing percutaneous coronary intervention
162. Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus‐eluting stents
163. Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN‐TAVI registry
164. TCT CONNECT-162 Predictors of Adverse Events in Patients Undergoing Cardiac Surgery Within 1 Year of PCI
165. TCT CONNECT-305 Impact of Lesion Location on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents for Unprotected Left Main Coronary Artery Stenosis
166. TCT CONNECT-64 Impact of DAPT Cessation in High Bleeding-Risk Patients Undergoing PCI: Insights From the PARIS Registry
167. TCT CONNECT-379 Adverse Outcomes in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease
168. TCT CONNECT-47 Impact of Sex at Birth on Long-Term Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
169. TCT CONNECT-307 Long-Term Outcomes After Coronary Intervention With Drug Eluting Stents for Unprotected Left Main Coronary Artery Stenosis According to Diabetes Mellitus Status
170. TCT CONNECT-378 Sex Disparities Among Patients Undergoing Complex Percutaneous Coronary Intervention (PCI): Insights From a Single-Center Large-Volume PCI Registry
171. TCT CONNECT-56 Prolonged Dual Antiplatelet Therapy in Patients With or Without Prior Myocardial Infarction: An Updated Systematic Review and Meta-Analysis
172. Guided and unguided de-escalation from potent P2Y12inhibitors among patients with acute coronary syndrome: a meta-analysis
173. Uncovering the Macrostructure of Tourists’ Preferences: a ChoiceExperiment Analysis of Tourism Demand to Sardinia
174. Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management
175. Residual SYNTAX Score and One-Year Outcome in Elderly Patients With Acute Coronary Syndrome
176. Ticagrelor in Patients With Cancer
177. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients
178. Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis
179. Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies
180. Periprocedural anticoagulation in non-ST-segment elevation acute coronary syndrome: time to reassess?
181. Device profile of the Resolute Onyx Zotarolimus eluting coronary stent system for the treatment of coronary artery disease: overview of its safety and efficacy
182. HIGH BLEEDING RISK AFTER PERCUTANEOUS CORONARY INTERVENTION: IMPACT OF RACE/ETHNICITY
183. ADDITIVE EFFECT OF MULTIPLE HIGH BLEEDING RISK CRITERIA IN PATIENTS UNDERGOING PCI
184. PERFORMANCE OF THE ACADEMIC RESEARCH CONSORTIUM FOR HIGH BLEEDING RISK CRITERIA ACCORDING TO SEX
185. THE EFFECT OF COMPLEX CORONARY REVASCULARIZATION PROCEDURE IN PATIENTS AT HIGH-BLEEDING RISK
186. The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN‐TAVI) registry
187. Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial
188. Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial
189. Ticagrelor Monotherapy After Coronary Stenting
190. TCT-833 Inflammatory Risk Status Is Age-Dependent in Women but Not in Men Undergoing Percutaneous Coronary Intervention
191. TCT-541 Validation of the Academic Research Consortium–High Bleeding Risk Criteria for Patients Undergoing Percutaneous Coronary Intervention
192. TCT-156 Patterns of Therapy Cessation in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Insights From the AVIATOR-2 International Registry
193. TCT-630 The Impact of Diabetes Mellitus in Patients Undergoing Percutaneous Coronary Intervention With a Drug Eluting Stent for Unprotected Left Main Stenosis
194. TCT-542 Impact of Baseline Anemia and Thrombocytopenia on 1-Year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention
195. TCT-803 Clinical Outcomes After TAVR in Patients With and Without Peripheral Arterial Disease: Results From the BRAVO-3 Randomized Trial
196. TCT-649 Long-Term Prognosis of Elderly Patients With Additional High Bleeding Risk Factors: A Pooled Analysis From 4 Post-Approval XIENCE Studies
197. TCT-544 Influence of Ischemic and Bleeding Risk Factors on Diabetic Patients Undergoing Percutaneous Coronary Intervention: From the Xience Pooled Registry
198. TCT-838 Prognostic Value of High-Sensitivity C-Reactive Protein in Percutaneous Coronary Intervention According to Body Mass Index
199. TCT-277 Global Differences in Predictors of Long-Term Outcomes After Percutaneous Coronary Intervention: Insights From the XIENCE Pooled Registry
200. TCT-294 Clinical Outcomes in Women and Minorities According to the Urgency of Percutaneous Coronary Intervention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.